1 |
|
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
135 |
1.670 |
SuperPathway |
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
Pathways |
- Constitutive Signaling by Aberrant PI3K in Cancer
- Negative regulation of the PI3K/AKT network
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- PI3K/AKT Signaling in Cancer
|
|
2 |
|
PI3K-Akt signaling pathway
|
390 |
1.359 |
SuperPathway |
- PI3K-Akt signaling pathway
|
Pathways |
- PI3K-Akt signaling pathway
- Focal adhesion: PI3K-Akt-mTOR-signaling pathway
|
|
3 |
|
PI3K / Akt Signaling
|
92 |
1.140 |
|
4 |
|
Development_Leptin signaling via PI3K-dependent pathway
|
52 |
1.140 |
SuperPathway |
- Development_Leptin signaling via PI3K-dependent pathway
|
Pathways |
- Development_Leptin signaling via PI3K-dependent pathway
|
|
5 |
|
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities
|
30 |
1.140 |
SuperPathway |
- PI3K-AKT-mTOR signaling pathway and therapeutic opportunities
|
Pathways |
- PI3K-AKT-mTOR signaling pathway and therapeutic opportunities
|
|
6 |
|
Class I PI3K signaling events
|
29 |
1.140 |
SuperPathway |
- Class I PI3K signaling events
|
Pathways |
- Class I PI3K signaling events
|
|
7 |
|
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids
|
7 |
1.140 |
SuperPathway |
- Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids
|
Pathways |
- Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids
|
|
8 |
|
PI3K/AKT/mTOR - vitamin D3 signaling
|
22 |
1.140 |
SuperPathway |
- PI3K/AKT/mTOR - vitamin D3 signaling
|
Pathways |
- PI3K/AKT/mTOR - vitamin D3 signaling
|
|
9 |
|
Class IB PI3K non-lipid kinase events
|
5 |
1.140 |
SuperPathway |
- Class IB PI3K non-lipid kinase events
|
Pathways |
- Class IB PI3K non-lipid kinase events
|
|
10 |
|
Signaling by NTRKs
|
134 |
0.750 |
Pathways |
- PI3K/AKT activation
- Activated NTRK3 signals through PI3K
|
|
11 |
|
Signaling by ERBB2 KD Mutants
|
29 |
0.750 |
Pathways |
- PI3K events in ERBB2 signaling
- PI3K events in ERBB4 signaling
|
|
12 |
|
DNA Damage
|
296 |
0.701 |
Genes names |
- SMG1 Nonsense Mediated MRNA Decay Associated PI3K Related Kinase
|
|
13 |
|
Peptide chain elongation
|
417 |
0.701 |
Genes names |
- SMG1 Nonsense Mediated MRNA Decay Associated PI3K Related Kinase
|
|
14 |
|
Processing of Capped Intron-Containing Pre-mRNA
|
745 |
0.701 |
Genes names |
- SMG1 Nonsense Mediated MRNA Decay Associated PI3K Related Kinase
|
|
15 |
|
Signaling by Erythropoietin
|
40 |
0.530 |
Pathways |
- Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
|
|
16 |
|
IL2 signaling events mediated by STAT5
|
74 |
0.530 |
Pathways |
- IL2 signaling events mediated by PI3K
|
|
17 |
|
Insulin receptor signalling cascade
|
87 |
0.530 |
|
18 |
|
Signaling events mediated by TCPTP
|
39 |
0.530 |
Pathways |
- MET activates PI3K/AKT signaling
|
|
19 |
|
Constitutive Signaling by AKT1 E17K in Cancer
|
38 |
0.530 |
Pathways |
- Class I PI3K signaling events mediated by Akt
|
|
20 |
|
Hepatocyte growth factor receptor signaling
|
115 |
0.530 |
Pathways |
- Trk receptor signaling mediated by PI3K and PLC-gamma
|
|
21 |
|
CD28 co-stimulation
|
119 |
0.530 |
Pathways |
- CD28 dependent PI3K/Akt signaling
|
|
22 |
|
Downstream signaling of activated FGFR2
|
51 |
0.530 |
Pathways |
- Activated NTRK2 signals through PI3K
|
|
23 |
|
Prolactin Signaling
|
432 |
0.530 |
Pathways |
- PI3K Signaling in B-Lymphocyte
|
|
24 |
|
Translation Insulin regulation of translation
|
183 |
0.530 |
Pathways |
- Development Growth hormone signaling via PI3K/AKT and MAPK cascades
|
|